JP2020007305A - Skin cleansing liquid composition - Google Patents
Skin cleansing liquid composition Download PDFInfo
- Publication number
- JP2020007305A JP2020007305A JP2019119217A JP2019119217A JP2020007305A JP 2020007305 A JP2020007305 A JP 2020007305A JP 2019119217 A JP2019119217 A JP 2019119217A JP 2019119217 A JP2019119217 A JP 2019119217A JP 2020007305 A JP2020007305 A JP 2020007305A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- liquid composition
- acid
- skin cleansing
- surfactant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 93
- 239000007788 liquid Substances 0.000 title claims abstract description 83
- 239000004094 surface-active agent Substances 0.000 claims abstract description 57
- 150000002148 esters Chemical class 0.000 claims abstract description 34
- 238000000034 method Methods 0.000 claims abstract description 13
- 238000004140 cleaning Methods 0.000 claims description 43
- 150000005215 alkyl ethers Chemical class 0.000 claims description 14
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 13
- CBFCDTFDPHXCNY-UHFFFAOYSA-N icosane Chemical compound CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 claims description 10
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 claims description 10
- PXGZQGDTEZPERC-UHFFFAOYSA-N 1,4-cyclohexanedicarboxylic acid Chemical group OC(=O)C1CCC(C(O)=O)CC1 PXGZQGDTEZPERC-UHFFFAOYSA-N 0.000 claims description 4
- 206010040880 Skin irritation Diseases 0.000 abstract description 20
- 230000036556 skin irritation Effects 0.000 abstract description 20
- 231100000475 skin irritation Toxicity 0.000 abstract description 20
- 239000007921 spray Substances 0.000 abstract description 11
- 238000005507 spraying Methods 0.000 abstract description 6
- 238000005187 foaming Methods 0.000 abstract description 5
- 230000001603 reducing effect Effects 0.000 abstract description 5
- 210000003491 skin Anatomy 0.000 description 132
- -1 fatty acid salt Chemical class 0.000 description 39
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 19
- 235000014113 dietary fatty acids Nutrition 0.000 description 17
- 239000000194 fatty acid Substances 0.000 description 17
- 229930195729 fatty acid Natural products 0.000 description 17
- 238000005406 washing Methods 0.000 description 17
- 235000010445 lecithin Nutrition 0.000 description 16
- 239000000787 lecithin Substances 0.000 description 16
- 229940067606 lecithin Drugs 0.000 description 16
- 125000004432 carbon atom Chemical group C* 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000003945 anionic surfactant Substances 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 239000002280 amphoteric surfactant Substances 0.000 description 10
- 230000003796 beauty Effects 0.000 description 10
- 150000004665 fatty acids Chemical class 0.000 description 10
- 239000006260 foam Substances 0.000 description 10
- 229930182490 saponin Natural products 0.000 description 10
- 150000007949 saponins Chemical class 0.000 description 10
- 235000017709 saponins Nutrition 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 9
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 8
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 8
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 229920006395 saturated elastomer Polymers 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 238000003556 assay Methods 0.000 description 7
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000004359 castor oil Substances 0.000 description 6
- 235000019438 castor oil Nutrition 0.000 description 6
- 210000002615 epidermis Anatomy 0.000 description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 5
- SUZRRICLUFMAQD-UHFFFAOYSA-N N-Methyltaurine Chemical compound CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 235000013922 glutamic acid Nutrition 0.000 description 5
- 239000004220 glutamic acid Substances 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- 239000002736 nonionic surfactant Substances 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 229960005261 aspartic acid Drugs 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- JNFDQAYPZCYWLD-UHFFFAOYSA-N bis[2-(2-ethoxyethoxy)ethyl] cyclohexane-1,4-dicarboxylate Chemical compound CCOCCOCCOC(=O)C1CCC(C(=O)OCCOCCOCC)CC1 JNFDQAYPZCYWLD-UHFFFAOYSA-N 0.000 description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 4
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 4
- 150000004671 saturated fatty acids Chemical class 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 4
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 4
- VCRXMSMANOGRCM-UHFFFAOYSA-N 2-(dodecanoylamino)butanedioic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(O)=O)CC(O)=O VCRXMSMANOGRCM-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000003704 aspartic acid Nutrition 0.000 description 3
- 239000012911 assay medium Substances 0.000 description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 229940031020 bis-ethoxydiglycol succinate Drugs 0.000 description 3
- MGQKBAKCRHGMEI-UHFFFAOYSA-N bis[2-(2-ethoxyethoxy)ethyl] butanedioate Chemical compound CCOCCOCCOC(=O)CCC(=O)OCCOCCOCC MGQKBAKCRHGMEI-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 3
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- IEXXLSKKBWIDAC-ZOWNYOTGSA-M sodium;(3s)-3-(dodecanoylamino)-4-hydroxy-4-oxobutanoate Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CC(O)=O IEXXLSKKBWIDAC-ZOWNYOTGSA-M 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 2
- IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- 231100000960 LabCyte EPI-MODEL 24 Toxicity 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000004996 alkyl benzenes Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 229940092714 benzenesulfonic acid Drugs 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 229960004365 benzoic acid Drugs 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- 229940071124 cocoyl glutamate Drugs 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 229940045996 isethionic acid Drugs 0.000 description 2
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 2
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 235000003441 saturated fatty acids Nutrition 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 2
- 229940082004 sodium laurate Drugs 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical compound OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- OQQOAWVKVDAJOI-UHFFFAOYSA-N (2-dodecanoyloxy-3-hydroxypropyl) dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCC OQQOAWVKVDAJOI-UHFFFAOYSA-N 0.000 description 1
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- PIGTXFOGKFOFTO-FVFWYJKVSA-N (2S,3S,4S,5R,6R)-6-[[(3S,4S,4aR,6aR,6bS,8R,8aR,12aS,14aR,14bR)-8a-carboxy-4-formyl-8-hydroxy-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound O([C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@@]1(C=O)C)C)(C)C[C@@H](O)[C@]1(CCC(C[C@H]14)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O PIGTXFOGKFOFTO-FVFWYJKVSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- LPMBTLLQQJBUOO-KTKRTIGZSA-N (z)-n,n-bis(2-hydroxyethyl)octadec-9-enamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)N(CCO)CCO LPMBTLLQQJBUOO-KTKRTIGZSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 1
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
- KVGOXGQSTGQXDD-UHFFFAOYSA-N 1-decane-sulfonic-acid Chemical compound CCCCCCCCCCS(O)(=O)=O KVGOXGQSTGQXDD-UHFFFAOYSA-N 0.000 description 1
- LDMOEFOXLIZJOW-UHFFFAOYSA-N 1-dodecanesulfonic acid Chemical compound CCCCCCCCCCCCS(O)(=O)=O LDMOEFOXLIZJOW-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- SLQVHWZLWVVHBD-UHFFFAOYSA-N 2-(2-oxotridecylamino)ethanesulfonic acid Chemical compound CCCCCCCCCCCC(=O)CNCCS(O)(=O)=O SLQVHWZLWVVHBD-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- WFSMVVDJSNMRAR-UHFFFAOYSA-N 2-[2-(2-ethoxyethoxy)ethoxy]ethanol Chemical compound CCOCCOCCOCCO WFSMVVDJSNMRAR-UHFFFAOYSA-N 0.000 description 1
- FAZHDESNRICLLX-UHFFFAOYSA-N 2-[methyl(tetradecanoyl)amino]ethanesulfonic acid Chemical compound CCCCCCCCCCCCCC(=O)N(C)CCS(O)(=O)=O FAZHDESNRICLLX-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
- ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 2-dodecanoyloxyethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCC ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- YHCCCMIWRBJYHG-UHFFFAOYSA-N 3-(2-ethylhexoxymethyl)heptane Chemical compound CCCCC(CC)COCC(CC)CCCC YHCCCMIWRBJYHG-UHFFFAOYSA-N 0.000 description 1
- KTCCLEVCNRHWQL-UHFFFAOYSA-N 3-(2-oxotridecylamino)propanoic acid;sodium Chemical compound [Na].CCCCCCCCCCCC(=O)CNCCC(O)=O KTCCLEVCNRHWQL-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- OXTNCQMOKLOUAM-UHFFFAOYSA-N 3-Oxoglutaric acid Chemical compound OC(=O)CC(=O)CC(O)=O OXTNCQMOKLOUAM-UHFFFAOYSA-N 0.000 description 1
- IXOCGRPBILEGOX-UHFFFAOYSA-N 3-[3-(dodecanoylamino)propyl-dimethylazaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O IXOCGRPBILEGOX-UHFFFAOYSA-N 0.000 description 1
- UNWFFCPRJXMCNV-UHFFFAOYSA-N 3-[dodecanoyl(methyl)amino]propanoic acid Chemical compound CCCCCCCCCCCC(=O)N(C)CCC(O)=O UNWFFCPRJXMCNV-UHFFFAOYSA-N 0.000 description 1
- DDGPBVIAYDDWDH-UHFFFAOYSA-N 3-[dodecyl(dimethyl)azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC(O)CS([O-])(=O)=O DDGPBVIAYDDWDH-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920006310 Asahi-Kasei Polymers 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- 239000001653 FEMA 3120 Substances 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 102100037611 Lysophospholipase Human genes 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N N-methylaminoacetic acid Natural products C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- VNQABZCSYCTZMS-UHFFFAOYSA-N Orthoform Chemical compound COC(=O)C1=CC=C(O)C(N)=C1 VNQABZCSYCTZMS-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 108010058864 Phospholipases A2 Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- KCLANYCVBBTKTO-UHFFFAOYSA-N Proparacaine Chemical compound CCCOC1=CC=C(C(=O)OCCN(CC)CC)C=C1N KCLANYCVBBTKTO-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 244000295923 Yucca aloifolia Species 0.000 description 1
- 235000004552 Yucca aloifolia Nutrition 0.000 description 1
- 235000012044 Yucca brevifolia Nutrition 0.000 description 1
- 235000017049 Yucca glauca Nutrition 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 150000001346 alkyl aryl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229960003150 bupivacaine Drugs 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229960002023 chloroprocaine Drugs 0.000 description 1
- VDANGULDQQJODZ-UHFFFAOYSA-N chloroprocaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1Cl VDANGULDQQJODZ-UHFFFAOYSA-N 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229940073499 decyl glucoside Drugs 0.000 description 1
- 229960001193 diclofenac sodium Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- TVACALAUIQMRDF-UHFFFAOYSA-N dodecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCOP(O)(O)=O TVACALAUIQMRDF-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229960000192 felbinac Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229940074049 glyceryl dilaurate Drugs 0.000 description 1
- 229940074045 glyceryl distearate Drugs 0.000 description 1
- 229940068939 glyceryl monolaurate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- FYAQQULBLMNGAH-UHFFFAOYSA-N hexane-1-sulfonic acid Chemical compound CCCCCCS(O)(=O)=O FYAQQULBLMNGAH-UHFFFAOYSA-N 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- XSEOYPMPHHCUBN-FGYWBSQSSA-N hydroxylated lecithin Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCC[C@@H](O)[C@H](O)CCCCCCCC XSEOYPMPHHCUBN-FGYWBSQSSA-N 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940031957 lauric acid diethanolamide Drugs 0.000 description 1
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 1
- 229940048848 lauryl glucoside Drugs 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 229960002373 loxoprofen Drugs 0.000 description 1
- WORCCYVLMMTGFR-UHFFFAOYSA-M loxoprofen sodium Chemical compound [Na+].C1=CC(C(C([O-])=O)C)=CC=C1CC1C(=O)CCC1 WORCCYVLMMTGFR-UHFFFAOYSA-M 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- INWLQCZOYSRPNW-UHFFFAOYSA-N mepivacaine Chemical compound CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C INWLQCZOYSRPNW-UHFFFAOYSA-N 0.000 description 1
- 229960002409 mepivacaine Drugs 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- XGZOMURMPLSSKQ-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)N(CCO)CCO XGZOMURMPLSSKQ-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-M nonanoate Chemical compound CCCCCCCCC([O-])=O FBUKVWPVBMHYJY-UHFFFAOYSA-M 0.000 description 1
- HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HPEOAUXDEAEVHA-UHFFFAOYSA-N octadecyl 2-(dimethylamino)acetate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CN(C)C HPEOAUXDEAEVHA-UHFFFAOYSA-N 0.000 description 1
- WLGDAKIJYPIYLR-UHFFFAOYSA-N octane-1-sulfonic acid Chemical compound CCCCCCCCS(O)(=O)=O WLGDAKIJYPIYLR-UHFFFAOYSA-N 0.000 description 1
- HEGSGKPQLMEBJL-RKQHYHRCSA-N octyl beta-D-glucopyranoside Chemical compound CCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HEGSGKPQLMEBJL-RKQHYHRCSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229950006098 orthocaine Drugs 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229940116257 pepper extract Drugs 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229960003981 proparacaine Drugs 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000003009 skin protective agent Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940037001 sodium edetate Drugs 0.000 description 1
- 239000004320 sodium erythorbate Substances 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- URLJMZWTXZTZRR-UHFFFAOYSA-N sodium myristyl sulfate Chemical compound CCCCCCCCCCCCCCOS(O)(=O)=O URLJMZWTXZTZRR-UHFFFAOYSA-N 0.000 description 1
- 229950005425 sodium myristyl sulfate Drugs 0.000 description 1
- 229940001482 sodium sulfite Drugs 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 description 1
- ZFDPAZDODACYOG-UHFFFAOYSA-M sodium;[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)amino]methanesulfonate Chemical compound [Na+].CN1C(C)=C(NCS([O-])(=O)=O)C(=O)N1C1=CC=CC=C1 ZFDPAZDODACYOG-UHFFFAOYSA-M 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 229940044609 sulfur dioxide Drugs 0.000 description 1
- 235000010269 sulphur dioxide Nutrition 0.000 description 1
- 229930185549 teaseedsaponin Natural products 0.000 description 1
- 229960002372 tetracaine Drugs 0.000 description 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、物理的摩擦を皮膚に与えなくても洗浄可能な皮膚洗浄用液体組成物に関する。 The present invention relates to a skin cleansing liquid composition that can be cleaned without applying physical friction to the skin.
皮膚を洗浄し、肌を清潔に保つことを目的とした製品として、洗顔料、ボディソープ、シャンプー等の様々な皮膚洗浄料組成物が提供されている。皮膚洗浄料組成物が皮膚を洗浄する機構においては、界面活性剤が汚れに吸着して汚れと水との間の表面張力を小さくし、摩擦による機械力も相まって、汚れを水中に浮き上がらせる。このような洗浄機構を有効に作用させるには、界面活性剤を臨界ミセル濃度以上で配合することが必要である。 Various skin cleansing compositions such as facial cleansers, body soaps, and shampoos have been provided as products intended to clean the skin and keep the skin clean. In the mechanism in which the skin cleansing composition cleans the skin, the surfactant adsorbs on the dirt to reduce the surface tension between the dirt and the water, and the dirt floats in the water in combination with the mechanical force due to friction. In order for such a washing mechanism to work effectively, it is necessary to mix a surfactant at a critical micelle concentration or higher.
一方で、界面活性剤による洗浄力が強すぎることで皮膚刺激の原因となり、その結果、乾燥肌とはじめとする肌トラブルが引き起こされているといった現状もある。このため、肌への作用をマイルドにすることを目的として、洗浄成分の組み合わせや配合量等を工夫する処方が種々提案されている。中でも、洗浄時に形成される泡が、肌と指とが直接触れて発生する摩擦を軽減すると認識されていることから、気泡力、泡持ち力等の泡質を向上させる処方は、肌への作用をマイルドにする処方として優れているというのが一般常識となっている。 On the other hand, there is also a current situation in which the detergency of a surfactant is too strong, causing skin irritation, and as a result, skin problems such as dry skin are caused. For this reason, for the purpose of making the action on the skin mild, various prescriptions have been proposed to devise the combination and amount of the cleaning components. Above all, since foams formed during washing are recognized to reduce friction generated by direct contact between the skin and finger, formulas that improve foam quality such as bubble power and foam holding power are applied to the skin. It is common general knowledge that it is an excellent prescription for mild action.
このため、近年では、ポンプフォーマータイプの皮膚洗浄料が種々提案されており、簡単に良質な泡が得られる手軽さだけでなく、肌への優しさも注目されている。具体的には、特許文献1に、フォーマー容器と、このフォーマー容器に充填されてなる液体皮膚洗浄剤組成物とからなる液体皮膚洗浄剤製品であって、上記液体皮膚洗浄剤組成物が、(A)炭素数7〜21の直鎖又は分岐鎖の一価炭化水素基を有する特定の脂肪酸塩を3〜10質量%と、(B)特定の塩化ジメチルジアリルアンモニウムとアクリル酸及び/又はアクリルアミドとの共重合体と、(C)糖アルコールとを含有し、(A)成分の含有量と(B)成分の含有量との質量比(A)/(B)が20〜250である液体皮膚洗浄剤製品が開示されている。また、特許文献2には、(a)脂肪酸塩を2〜9質量%、(b)ラウリルジメチルアミノ酢酸ベタインを0.5〜4質量%、(c)2価アルコールの1種類または2種類以上を1〜10質量%を含有し、かつ、(a)成分と(b)成分の配合量(質量%)の和(a)+(b)が3〜10質量%、配合量比(b)/(a)が0.1〜0.5である洗浄剤をフォーマー容器に充填したことを特徴とする皮膚洗浄剤組成物が開示されている。さらに、特許文献3には、(a)ラウリルジメチルアミノ酢酸ベタインと、(b)炭素数5〜25の脂肪酸から形成され且つ特定組成の高級脂肪酸石鹸4〜15質量%と、を含有するフォーマー容器で吐出される洗浄料組成物が開示されている。 For this reason, in recent years, various pump-former type skin cleansing agents have been proposed, and attention has been paid to not only the convenience of easily obtaining high-quality foam but also the gentleness on the skin. Specifically, Patent Document 1 discloses a liquid skin cleansing product comprising a former container and a liquid skin cleanser composition filled in the former container, wherein the liquid skin cleanser composition comprises ( A) 3 to 10% by mass of a specific fatty acid salt having a linear or branched monovalent hydrocarbon group having 7 to 21 carbon atoms, and (B) a specific dimethyldiallylammonium chloride and acrylic acid and / or acrylamide. And a (C) sugar alcohol, wherein the mass ratio (A) / (B) of the content of the component (A) to the content of the component (B) is from 20 to 250. A cleaning product is disclosed. Patent Document 2 discloses that (a) 2 to 9% by mass of a fatty acid salt, (b) 0.5 to 4% by mass of betaine lauryldimethylaminoacetate, and (c) one or more kinds of dihydric alcohols And the sum (a) + (b) of the compounding amounts (% by mass) of the components (a) and (b) is 3 to 10% by mass, and the compounding ratio (b) A skin cleanser composition characterized by filling a former container with a cleanser having / (a) of 0.1 to 0.5 is disclosed. Further, Patent Document 3 discloses a former container containing (a) betaine lauryldimethylaminoacetate and (b) 4 to 15% by mass of a higher fatty acid soap formed of a fatty acid having 5 to 25 carbon atoms and having a specific composition. Discloses a cleaning composition which is discharged in the following manner.
ポンプフォーマータイプの皮膚洗浄料組成物は、界面活性剤の配合量が比較的少なく、その点で、固形状や半固形状の皮膚洗浄料組成物に比べて皮膚への刺激は低減されている傾向にあると考えられる。一方で、ポンプフォーマータイプの皮膚洗浄料組成物は、泡の
状態で吐出されることが大前提となっているため、気泡力を発揮させるために必要な最低限の界面活性剤を配合することがその構成上不可避となっている。
The pump former type skin cleansing composition has a relatively small amount of a surfactant, and in that respect, irritation to the skin is reduced as compared with a solid or semi-solid skin cleansing composition. It seems that there is a tendency. On the other hand, since the pump-former type skin cleansing composition is premised on being discharged in the form of foam, the minimum surfactant necessary for exerting the foaming power is blended. This is inevitable in its configuration.
近年、肌に優しい洗顔への意識はますます高まってきている。それと共に、時短スキンケアにも注目が集まり、敏感肌にも優しく、且つ素早く洗浄可能な皮膚洗浄料が期待されている。 In recent years, there has been an increasing awareness of cleansing the skin. At the same time, attention has also been paid to time-saving skin care, and a skin cleanser that is gentle on sensitive skin and that can be quickly cleaned is expected.
メイク落とし(クレンジング)を目的とした皮膚洗浄料を除く、皮脂や汗等の体液や汚れ等の除去を目的とした皮膚洗浄料は様々創出されているが、どの皮膚洗浄料も例外なく、肌へ適用する前に泡立てることを前提としており、また、洗浄前によく泡立てることは、肌への摩擦を和らげる点で好ましいということも常識化している。泡は、肌と手との間に介在することで物理的摩擦を和らげることができるものの、泡自体が肌にこすりつけられるため、それ自体が物理的摩擦を生じさせ、肌への刺激になっていることには変わりない。特に、エステサロンや美容院では、顔等の洗浄施術が行われることがあり、サービスの質の向上のため、より肌に優しい洗浄施術が望まれる。 Various skin cleansing agents have been created to remove body fluids such as sebum and sweat, and dirt, etc., excluding skin cleansing agents for the purpose of cleansing. It is presumed that whipping before application to the skin is premised, and that whipping well before washing is preferable in terms of reducing friction to the skin. Foam can reduce physical friction by intervening between the skin and hands, but because the foam itself rubs against the skin, it creates physical friction itself and stimulates the skin Is still there. In particular, in a beauty salon or a beauty salon, a cleaning treatment of the face or the like may be performed, and a cleaning treatment that is gentler to the skin is desired in order to improve the quality of service.
そこで本発明は、物理的摩擦を皮膚に与えなくても洗浄可能な皮膚洗浄用液体組成物を提供することを目的とする。 Therefore, an object of the present invention is to provide a skin cleaning liquid composition that can be cleaned without applying physical friction to the skin.
本発明者は、肌への刺激をより軽減させるため、肌への適用に際して予め泡立てることなく、直接的に皮膚洗浄用液体組成物を肌へ適用し、物理的摩擦を皮膚に与えることなく洗浄するという斬新な用途の着想に至った。さらに、界面活性剤に両親媒性エステルを共存させることによって、物理的摩擦を皮膚に与えなくとも効果的に洗浄力が得られることを見出した。本発明は、この知見に基づいてさらに検討を重ねることにより完成したものである。 The present inventor, in order to further reduce the irritation to the skin, without applying foam to the skin beforehand, apply the liquid composition for skin cleansing directly to the skin, wash without applying physical friction to the skin This led to the idea of a novel use. Furthermore, they have found that the coexistence of an amphipathic ester with a surfactant can effectively provide detergency without applying physical friction to the skin. The present invention has been completed by further study based on this finding.
即ち、本発明は、下記に掲げる態様の発明を提供する。
項1. (A)界面活性剤と(B)両親媒性エステルとを含有し、物理的摩擦を皮膚に与えることなく洗浄するために用いられる、皮膚洗浄用液体組成物。
項2. 前記(B)成分が、ジカルボン酸ビス(ポリオキシアルキレンアルキルエーテル)エステルおよび(エイコサン二酸/テトラデカン二酸)ポリグリセリル−10よりなる群から選ばれる、項1に記載の皮膚洗浄用液体組成物。
項3. 前記ジカルボン酸ビス(ポリオキシアルキレンアルキルエーテル)エステルが、シクロヘキサン−1,4−ジカルボン酸ビスエトキシジグリコールである、項2に記載の皮膚洗浄用液体組成物。
項4. 前記(A)成分の含有量が0.025〜2重量%である、項1〜3のいずれかに記載の皮膚洗浄用液体組成物。
項5. 前記(A)成分の含有量が0.025〜0.9重量%である、項4に記載の皮膚洗浄用液体組成物。
項6. (A)界面活性剤と(B)両親媒性エステルとを含有する皮膚洗浄用液体組成物を、物理的摩擦を皮膚に与えることなく皮膚に適用することを含む、皮膚洗浄方法。
That is, the present invention provides the following aspects of the invention.
Item 1. A skin cleansing liquid composition comprising (A) a surfactant and (B) an amphipathic ester and used for cleaning without giving physical friction to the skin.
Item 2. Item 2. The skin cleansing liquid composition according to Item 1, wherein the component (B) is selected from the group consisting of a dicarboxylic acid bis (polyoxyalkylene alkyl ether) ester and (eicosane diacid / tetradecane diacid) polyglyceryl-10.
Item 3. Item 3. The skin cleansing liquid composition according to Item 2, wherein the dicarboxylic acid bis (polyoxyalkylene alkyl ether) ester is cyclohexane-1,4-dicarboxylic acid bisethoxydiglycol.
Item 4. Item 4. The liquid composition for cleaning skin according to any one of Items 1 to 3, wherein the content of the component (A) is 0.025 to 2% by weight.
Item 5. Item 5. The liquid composition for cleaning skin according to Item 4, wherein the content of the component (A) is 0.025 to 0.9% by weight.
Item 6. A skin cleansing method comprising applying a skin cleansing liquid composition containing (A) a surfactant and (B) an amphiphilic ester to the skin without imparting physical friction to the skin.
本発明の皮膚洗浄用液体組成物によれば、皮膚刺激性が低減されつつも優れた洗浄力を発揮することができるため、肌への適用に際して予め泡立てることなく、物理的摩擦を皮膚に与えずに洗浄可能となる。物理的摩擦を皮膚に与えずに洗浄可能であるため、皮膚洗浄用液体組成物における界面活性剤の配合量を、従前の皮膚洗浄用液体組成物に含まれる配合量よりも大幅に低減させることができ、これによってより一層皮膚刺激性を低減させることも可能である。 According to the liquid composition for skin cleansing of the present invention, it is possible to exert excellent detergency while reducing skin irritation, thus giving physical friction to the skin without foaming before application to the skin. Cleaning is possible. Since the washing can be performed without giving physical friction to the skin, the amount of the surfactant in the skin cleaning liquid composition is significantly reduced from that in the conventional skin cleaning liquid composition. This can further reduce skin irritation.
1.皮膚洗浄用液体組成物
本発明の皮膚洗浄用液体組成物は、(A)界面活性剤(以下、(A)成分と表記することがある)と(B)両親媒性エステル(以下、(B)成分と表記することがある)とを含有することを特徴とする。以下、本発明の皮膚洗浄用液体組成物について詳述する。
1. Liquid composition for skin cleansing The liquid composition for skin cleansing of the present invention comprises (A) a surfactant (hereinafter sometimes referred to as a component (A)) and (B) an amphiphilic ester (hereinafter referred to as (B) ) Component). Hereinafter, the skin cleansing liquid composition of the present invention will be described in detail.
(A)界面活性剤
本発明の皮膚洗浄用液体組成物は、(A)成分として界面活性剤を含有する。界面活性剤としては特に限定されないが、皮膚への刺激を抑制する観点から、好ましくはアニオン性界面活性剤、非イオン性界面活性剤、両性界面活性剤、天然界面活性剤等が挙げられる。界面活性剤としては、アニオン性界面活性剤、非イオン性界面活性剤、両性界面活性剤、天然界面活性剤の中から1種を単独で使用してもよく、また2種以上を任意に組み合わせて使用してもよい。
(A) Surfactant The liquid composition for skin cleansing of the present invention contains a surfactant as the component (A). The surfactant is not particularly limited, but preferably includes an anionic surfactant, a nonionic surfactant, an amphoteric surfactant, and a natural surfactant from the viewpoint of suppressing irritation to the skin. As the surfactant, one of anionic surfactants, nonionic surfactants, amphoteric surfactants, and natural surfactants may be used alone, or two or more surfactants may be arbitrarily combined. May be used.
本発明に使用されるアニオン性界面活性剤としては、例えば、カルボン酸型、スルホン酸型、硫酸エステル型、リン酸エステル型等の界面活性剤が挙げられる。 Examples of the anionic surfactant used in the present invention include carboxylic acid type, sulfonic acid type, sulfate ester type and phosphate ester type surfactants.
カルボン酸型の界面活性剤としては、具体的には、オクタン酸、デカン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸等の炭素数6〜22の飽和又は不飽和脂肪酸;オクタノイル基、デカノイル基、ラウロイル基、ミリストイル基、パルミトイル基、ココイル基等の炭素数8〜24の飽和又は不飽和のN−アシル基を有するN−アシルアミノ酸(カルボン酸型アミノ酸系アニオン性界面活性剤)が挙げられる。カルボン酸型アミノ酸系アニオン性界面活性剤におけるN−アシルアミノ酸としては、N−アシルサルコシン、N−アシルアスパラギン酸、N−アシルグルタミン酸、ラウロイルメチル-β-アラニン等が挙げられる。より具体的なカルボン酸型アミノ酸系アニオン性界面活性剤としては、N−ラウロイルサルコシン、N-ラウロイルアスパラギン酸、ココイルグルタミン酸、ラウロイルメチル-β-アラニンナトリウム等が挙げられる。 Specific examples of the carboxylic acid type surfactant include saturated or unsaturated fatty acids having 6 to 22 carbon atoms such as octanoic acid, decanoic acid, lauric acid, myristic acid, palmitic acid, and stearic acid; octanoyl group, decanoyl N-acylamino acids (carboxylic acid-type amino acid-based anionic surfactants) having a saturated or unsaturated N-acyl group having 8 to 24 carbon atoms such as a group, lauroyl group, myristoyl group, palmitoyl group, cocoyl group and the like. Can be Examples of the N-acyl amino acid in the carboxylic acid type amino acid anionic surfactant include N-acyl sarcosine, N-acyl aspartic acid, N-acyl glutamic acid, lauroylmethyl-β-alanine and the like. More specific carboxylic acid-type amino acid-based anionic surfactants include N-lauroylsarcosine, N-lauroylaspartic acid, cocoylglutamic acid, sodium lauroylmethyl-β-alanine, and the like.
スルホン酸型の界面活性剤としては、具体的には、ココイルイセチオン酸等の炭素数6〜22の脂肪酸とイセチオン酸のエステル;ヘキサンスルホン酸、オクタンスルホン酸、デカンスルホン酸、ドデカンスルホン酸等の炭素数6〜22のアルキルスルホン酸;アルキルベンゼンスルホン酸等の炭素数10〜16のアルキル基を有するアルキルベンゼンスルホン酸;オクタノイル基、デカノイル基、ラウロイル基、ミリストイル基、パルミトイル基、ココイル基等の炭素数8〜24の飽和又は不飽和のN−アシル基を有するN−アシル−N−メチルタウリン(スルホン酸型アミノ酸系アニオン性界面活性剤)が挙げられる。より具体的なスルホン酸型アミノ酸系アニオン性界面活性剤としては、N−ミリストイル−N−メチルタウリン、N−ラウロイルメチルタウリン、ココイルメチルタウリン等が挙げられる。 Specific examples of the sulfonic acid type surfactant include esters of fatty acids having 6 to 22 carbon atoms such as cocoyl isethionic acid and isethionic acid; hexanesulfonic acid, octanesulfonic acid, decanesulfonic acid, dodecanesulfonic acid and the like. Alkyl sulfonic acid having 6 to 22 carbon atoms such as alkyl benzene sulfonic acid; alkyl benzene sulfonic acid having an alkyl group having 10 to 16 carbon atoms such as octanoyl group, decanoyl group, lauroyl group, myristoyl group, palmitoyl group, cocoyl group, etc. N-acyl-N-methyltaurine having a saturated or unsaturated N-acyl group of Formulas 8 to 24 (sulfonic acid type amino acid-based anionic surfactant). More specific sulfonic acid type amino acid anionic surfactants include N-myristoyl-N-methyltaurine, N-lauroylmethyltaurine, cocoylmethyltaurine and the like.
硫酸エステル型の界面活性剤としては、具体的には、ラウリル硫酸、ミリスチル硫酸等の炭素数10〜22の飽和又は不飽和脂肪酸と硫酸のエステル等が挙げられる。リン酸エステル型の界面活性剤としては、具体的には、ラウリルリン酸等の炭素数8〜24の飽和又は不飽和脂肪酸とリン酸のエステル等が挙げられる。 Specific examples of the sulfate ester type surfactant include esters of a saturated or unsaturated fatty acid having 10 to 22 carbon atoms, such as lauryl sulfate and myristyl sulfate, with sulfuric acid. Specific examples of the phosphoric acid ester type surfactant include esters of phosphoric acid with a saturated or unsaturated fatty acid having 8 to 24 carbon atoms such as lauryl phosphoric acid.
なお、これらのアニオン性界面活性剤は、塩の形態であってもよく、例えば、ナトリウム塩、カリウム塩等のアルカリ金属塩;トリエタノールアミン(TEA)塩;アンモニウム塩等の形態をとることができる。 These anionic surfactants may be in the form of a salt, for example, an alkali metal salt such as a sodium salt or a potassium salt; a triethanolamine (TEA) salt; an ammonium salt or the like. it can.
これらのアニオン性界面活性剤の中でも、皮膚刺激低減性及び洗浄力をより良好に得る観点から、好ましくはカルボン酸型の界面活性剤及びスルホン酸型の界面活性剤が挙げられ、より好ましくは、ラウリン酸、N-ラウロイルアスパラギン酸、ココイルグルタミン酸、ココイルメチルタウリン及びこれらの塩が挙げられ、さらに好ましくは、ラウリン酸ナトリウム、N-ラウロイルアスパラギン酸ナトリウム、ココイルグルタミン酸トリエタノールアミン、ココイルメチルタウリンナトリウムが挙げられる。さらにこれらの中でも、皮膚刺激低減性を一層良好に得る観点から、好ましくは炭素数8〜24の飽和又は不飽和のアシル基を有するN−アシルグルタミン酸及び炭素数8〜22の脂肪酸アミドスルホン酸及びこれらの塩が挙げられ、より好ましくはココイルグルタミン酸、ココイルメチルタウリン及びこれらの塩が挙げられ、さらに好ましくはココイルグルタミン酸トリエタノールアミン、ココイルメチルタウリンナトリウムが挙げられ、また、洗浄力を一層良好に得る観点から、好ましくは炭素数8〜24の飽和又は不飽和のアシル基を有するN−アシルアスパラギン酸が挙げられ、より好ましくはN-ラウロイルアスパラギン酸が挙げられ、さらに好ましくはN-ラウロイルアスパラギン酸ナトリウムが挙げられる。 Among these anionic surfactants, from the viewpoint of better obtaining skin irritation reduction and detergency, preferably carboxylic acid type surfactants and sulfonic acid type surfactants, more preferably, Lauric acid, N-lauroyl aspartic acid, cocoyl glutamic acid, cocoyl methyl taurine and salts thereof, more preferably, sodium laurate, sodium N-lauroyl aspartate, cocoyl glutamate triethanolamine, cocoyl methyl taurine sodium. Can be Further, among these, from the viewpoint of further improving skin irritation reduction, preferably N-acylglutamic acid having a saturated or unsaturated acyl group having 8 to 24 carbon atoms and fatty acid amide sulfonic acid having 8 to 22 carbon atoms, These salts include, more preferably, cocoyl glutamic acid, cocoyl methyl taurine and salts thereof, further preferably, cocoyl glutamic acid triethanolamine, cocoyl methyl taurine sodium, and furthermore, the detergency is more preferably obtained. From the viewpoint, preferably, N-acyl aspartic acid having a saturated or unsaturated acyl group having 8 to 24 carbon atoms is used, more preferably, N-lauroyl aspartic acid is used, and even more preferably, sodium N-lauroyl aspartate is used. Is mentioned.
これらのアニオン性界面活性剤は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。 These anionic surfactants may be used alone or in a combination of two or more.
本発明に使用される非イオン性界面活性剤としては、例えば、エステル型、エーテル型、エステル・エーテル型、アルカノールアミド型、アルキルグリコシド型、アルコール型等の界面活性剤が挙げられる。 Examples of the nonionic surfactant used in the present invention include surfactants of ester type, ether type, ester ether type, alkanolamide type, alkyl glycoside type, alcohol type and the like.
エステル型の界面活性剤としては、具体的には、ジラウリン酸グリコール、モノステアリン酸グリコール、ジステアリン酸グリコール、モノラウリン酸グリセリル、ジラウリン酸グリセリル、モノステアリン酸グリセリル、ジステアリン酸グリセリル等の炭素数8〜20の飽和又は不飽和脂肪酸とグリセリンのモノ又はジエステル;ソルビタン脂肪酸エステル;ショ糖脂肪酸エステル等が挙げられる。 Specific examples of the ester type surfactant include those having 8 to 20 carbon atoms such as glycol dilaurate, glycol monostearate, glycol distearate, glyceryl monolaurate, glyceryl dilaurate, glyceryl monostearate, and glyceryl distearate. Mono- or diesters of glycerin with saturated or unsaturated fatty acids; sorbitan fatty acid esters; sucrose fatty acid esters.
エーテル型の界面活性剤としては、具体的には、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンアルキルフェニルエーテル、ポリオキシエチレンポリオキシプロピレングリコール等が挙げられる。 Specific examples of the ether type surfactant include polyoxyethylene alkyl ether, polyoxyethylene alkyl phenyl ether, polyoxyethylene polyoxypropylene glycol, and the like.
エステル・エーテル型の界面活性剤としては、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンヘキシタン脂肪酸エステル、ソルビタン脂肪酸エステルポリエチレングリコール等が挙げられる。 Examples of the ester / ether type surfactant include polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene hexitan fatty acid ester, and sorbitan fatty acid ester polyethylene glycol.
アルカノールアミド型の界面活性剤としては、具体的には、コカミドDEA(ヤシ油脂肪酸ジエタノールアミド)、ラウリン酸ジエタノールアミド、オレイン酸ジエタノールアミド、ステアリン酸ジエタノールアミド等が挙げられる。 Specific examples of the alkanolamide-type surfactant include cocamide DEA (coconut oil fatty acid diethanolamide), lauric acid diethanolamide, oleic acid diethanolamide, and stearic acid diethanolamide.
アルキルグリコシド型界面活性剤としては、具体的には、オクチルグルコシド、デシルグルコシド、ラウリルグルコシド等が挙げられる。 Specific examples of the alkyl glycoside surfactant include octyl glucoside, decyl glucoside, lauryl glucoside, and the like.
アルコール型の界面活性剤としては、セタノール、ステアリルアルコール、オレイルアルコール等が挙げられる。 Examples of the alcohol type surfactant include cetanol, stearyl alcohol, oleyl alcohol and the like.
これらの非イオン性界面活性剤の中でも、皮膚刺激低減性及び洗浄力をより良好に得る観点から、好ましくは、エステル・エーテル型の界面活性剤及びアルカノールアミド型の界面活性剤が挙げられ、より好ましくは、ポリオキシエチレン硬化ヒマシ油及びコカミドDEAが挙げられ、さらに好ましくはポリオキシエチレン硬化ヒマシ油が挙げられる。 Among these nonionic surfactants, from the viewpoint of obtaining better skin irritation reduction and detergency, preferably ester-ether type surfactants and alkanolamide type surfactants, Preferably, polyoxyethylene hydrogenated castor oil and cocamide DEA are used, and more preferably, polyoxyethylene hydrogenated castor oil is used.
これらの非イオン性界面活性剤は、1種単独で使用してもよく、また2種以上を組み合
わせて使用してもよい。
These nonionic surfactants may be used alone or in a combination of two or more.
本発明に使用される両性界面活性剤としては、例えば、アルキルベタイン型、脂肪酸アミドプロピルベタイン型、アミンオキシド型等の界面活性剤が例示される。 Examples of the amphoteric surfactant used in the present invention include surfactants of alkyl betaine type, fatty acid amide propyl betaine type, amine oxide type and the like.
アルキルベタイン型の界面活性剤としては、具体的には、ラウリルジメチルアミノ酢酸ベタイン、ステアリルジメチルアミノ酢酸ベタイン、オクタデシルアミノメチルジメチルスルホプロピルベタイン等が挙げられる。 Specific examples of the alkylbetaine type surfactant include betaine lauryl dimethylaminoacetate, betaine stearyl dimethylaminoacetate, and octadecylaminomethyldimethylsulfopropyl betaine.
脂肪酸アミドプロピルベタイン型両性界面活性剤としては、具体的には、コカミドプロピルベタイン等のアミドベタイン(アミノ酸系両性界面活性剤)、コカミドプロピルヒドロキシスルタイン等のスルホベタイン等が挙げられる。 Specific examples of the fatty acid amidopropyl betaine-type amphoteric surfactant include amidobetaine (amino acid-based amphoteric surfactant) such as cocamidopropyl betaine and sulfobetaine such as cocamidopropylhydroxysultaine.
アミンオキシド型両性界面活性剤としては、具体的には、ラウリルジメチルアミンN‐オキシド、オレイルジメチルアミンN‐オキシド等が挙げられる。 Specific examples of the amine oxide type amphoteric surfactant include lauryl dimethylamine N-oxide, oleyldimethylamine N-oxide and the like.
なお、これらの両性界面活性剤は、塩の形態であってもよく、例えば、ナトリウム塩、カリウム塩等のアルカリ金属塩;トリエタノールアミン(TEA)塩;アンモニウム塩等の形態をとることができる。 These amphoteric surfactants may be in the form of a salt, for example, an alkali metal salt such as a sodium salt or a potassium salt; a triethanolamine (TEA) salt; an ammonium salt or the like. .
これらの両性界面活性剤の中でも、皮膚刺激低減性及び洗浄力をより良好に得る観点から、好ましくは脂肪酸アミドプロピルベタイン型界面活性剤が挙げられ、より好ましくはコカミドプロピルベタイン等のアミドベタイン(アミノ酸系両性界面活性剤)が挙げられ、さらに好ましくはコカミドプロピルベタインが挙げられる。 Among these amphoteric surfactants, fatty acid amide propyl betaine-type surfactants are preferred from the viewpoint of better skin irritation reduction and detergency, and amide betaines such as cocamidopropyl betaine are more preferred. Amino acid-based amphoteric surfactant), and more preferably cocamidopropyl betaine.
これらの両性界面活性剤は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。 These amphoteric surfactants may be used alone or in a combination of two or more.
本発明に使用される天然界面活性剤としては、レシチン及びリゾレシチン;キラヤサポニン、ダイズサポニン、ユッカサポニン、エンジュサポニン、ビートサポニン、アズキサポニン、ニンジンサポニン、茶種サポニン、ヘチマサポニン、ツボクササポニンなどのサポニン等が挙げられる。 Examples of the natural surfactants used in the present invention include lecithin and lysolecithin; saponins such as quillaja saponin, soybean saponin, yucca saponin, endusa saponin, beet saponin, azusaponin, carrot saponin, tea seed saponin, hemima saponin, tsukusa saponin and the like. And the like.
レシチンは、ホスファチジルコリン、ホスファチジルエタノールアミン、ホスファチジルセリン、ホスファチジルイノシトールなどのリン脂質と、トリグリセリド、脂肪酸、植物油からの炭水化物などの成分との混合物であり、医薬品、医薬部外品、化粧品において公知の成分である。 Lecithin is a mixture of phospholipids such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and phosphatidylinositol, and components such as triglycerides, fatty acids, and carbohydrates from vegetable oils. is there.
レシチンとしては、動植物由来の天然レシチン(例えば、大豆レシチン、卵黄レシチン等)そのものであってもよいし、天然レシチンの化学処理物であってもよいし、天然レシチンの精製物であってもよい。天然レシチンの化学処理物としては、水素添加処理により得られた水素添加レシチン(例えば、完全水素添加レシチンや部分水素添加レシチン)、水酸化処理により得られた水酸化レシチン等が挙げられる。天然レシチンの精製物としては、アセトン等の溶剤によりホスファチジルコリンの含有量を高めたレシチンが挙げられる。 The lecithin may be natural lecithin derived from animals and plants (for example, soybean lecithin, egg yolk lecithin, etc.) itself, a chemically treated natural lecithin, or a purified natural lecithin. . Examples of the chemically treated natural lecithin include hydrogenated lecithin obtained by hydrogenation treatment (for example, completely hydrogenated lecithin and partially hydrogenated lecithin), and hydroxylated lecithin obtained by hydroxylation treatment. Examples of the purified natural lecithin include lecithin in which the content of phosphatidylcholine is increased by a solvent such as acetone.
リゾレシチンとしては、上記のレシチン(天然レシチン、天然レシチンの化学処理物、天然レシチンの精製物)のリゾ体が挙げられる。リゾレシチンは、レシチンをホスホリパーゼA2などの酵素による加水分解(溶解)でホスファチジルコリンの2位の脂肪酸が除去された構造を有する。 Examples of lysolecithin include lyso-forms of the above-mentioned lecithin (natural lecithin, a chemically-treated natural lecithin, and a purified natural lecithin). Lysolecithin has a structure in which the fatty acid at position 2 of phosphatidylcholine has been removed by hydrolyzing (dissolving) lecithin with an enzyme such as phospholipase A2.
これらの天然界面活性剤の中でも、皮膚刺激低減性及び洗浄力をより良好に得る観点から、好ましくはレシチン及びリゾレシチン並びにサポニンが挙げられ、より好ましくはレシチン及びリゾレシチンが挙げられ、さらに好ましくはリゾレシチンが挙げられる。 Among these natural surfactants, preferably lecithin, lysolecithin and saponin are mentioned from the viewpoint of better skin irritation reduction and detergency, more preferably lecithin and lysolecithin, and even more preferably lysolecithin. No.
これらの天然界面活性剤は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。 These natural surfactants may be used alone or in a combination of two or more.
本発明の皮膚洗浄剤液体組成物における(A)成分の含有量は特に限定されず、付与すべき洗浄力に応じて適宜決定することができる。本発明の皮膚洗浄剤液体組成物は、物理的摩擦を皮膚に与えることなく洗浄することが可能であるため、皮膚洗浄用液体組成物における界面活性剤の配合量を、従前の皮膚洗浄用液体組成物に含まれる配合量よりも大幅に低減させることができ、本来的には有効な洗浄力を発揮できないような少量の界面活性剤量であっても効果的に洗浄力を発揮することができる。このような観点から、本発明の皮膚洗浄剤液体組成物における(A)成分の含有量としては、好ましくは0.025〜2重量%、より好ましくは0.025〜1.5重量%以下、さらに好ましくは0.025〜1重量%以下、特に好ましくは0.025〜0.9重量%以下が挙げられる。このように界面活性剤量が少量であることより、皮膚刺激性を各段に低減することができる。また、より優れた洗浄力を得る観点からは、(A)成分の上記含有量の範囲の下限としては、0.1重量%以上であることが好ましく、0.5重量%以上であることがより好ましい。 The content of the component (A) in the skin cleanser liquid composition of the present invention is not particularly limited, and can be appropriately determined according to the detergency to be provided. Since the skin cleansing liquid composition of the present invention can be washed without giving physical friction to the skin, the amount of the surfactant in the skin cleansing liquid composition can be reduced by the conventional skin cleansing liquid. It can be significantly reduced than the amount contained in the composition, and it can effectively exert detergency even with a small amount of surfactant such that it cannot inherently exhibit effective detergency it can. From such a viewpoint, the content of the component (A) in the skin cleanser liquid composition of the present invention is preferably 0.025 to 2% by weight, more preferably 0.025 to 1.5% by weight or less, More preferably, the content is 0.025 to 1% by weight or less, particularly preferably 0.025 to 0.9% by weight or less. Since the amount of the surfactant is small as described above, skin irritation can be further reduced. From the viewpoint of obtaining more excellent detergency, the lower limit of the content of the component (A) is preferably 0.1% by weight or more, and more preferably 0.5% by weight or more. More preferred.
(B)両親媒性エステル
本発明の皮膚洗浄用液体組成物は、(B)成分として両親媒性エステルを含有する。(B)成分は単独で洗浄作用を示さないが、(A)成分と共存させることによって、低刺激性を維持しながら皮膚洗浄用液体組成物の洗浄力を向上させることができる。
(B) Amphipathic ester The liquid composition for skin cleansing of the present invention contains an amphipathic ester as the component (B). The component (B) alone does not exhibit a detergency, but the coexistence with the component (A) can improve the detergency of the liquid composition for skin cleansing while maintaining low irritation.
本発明において、両親媒性エステルは、日本薬局方一般試験法に定められた方法による測定で、導電率70〜110μs/mに調整されたイオン交換水に常温で2質量%以上溶解し、かつ、油剤であるイソノナン酸イソトリデシル(日清オイリオグループ社製、サラコス913)にも常温(25℃)で10質量%以上溶解するものであり、エステル系界面活性剤は除かれる。 In the present invention, the amphiphilic ester is dissolved in ion-exchanged water adjusted to have a conductivity of 70 to 110 μs / m at room temperature in an amount of 2% by mass or more, as measured by the method specified in the Japanese Pharmacopoeia General Test Method, and It is also soluble in isotridecyl isononanoate (Salacos 913, manufactured by Nisshin Oillio Group) at room temperature (25 ° C.) in an amount of 10% by mass or more, and excludes ester surfactants.
両親媒性エステルとしては特に限定されないが、皮膚刺激低減性及び洗浄力をより良好に得る観点から、ジカルボン酸ビス(ポリオキシアルキレンアルキルエーテル)エステル及び(エイコサン二酸/テトラデカン二酸)ポリグリセリル−10よりなる群から選ばれるものであることが好ましい。両親媒性エステルとしては、ジカルボン酸ビス(ポリオキシアルキレンアルキルエーテル)エステル及び(エイコサン二酸/テトラデカン二酸)ポリグリセリル−10の中からいずれかを単独で使用してもよく、また両方を組み合わせて使用してもよい。これらの両親媒性エステルの中でも、皮膚刺激低減性及び洗浄力をより良好に得る観点から、ジカルボン酸ビス(ポリオキシアルキレンアルキルエーテル)エステルがより好ましい。 The amphiphilic ester is not particularly limited, but from the viewpoint of better skin irritation reduction and detergency, bis (polyoxyalkylene alkyl ether) dicarboxylate and (eicosane diacid / tetradecane diacid) polyglyceryl-10 are preferred. It is preferably selected from the group consisting of: As the amphiphilic ester, any one of dicarboxylic acid bis (polyoxyalkylene alkyl ether) ester and (eicosane diacid / tetradecane diacid) polyglyceryl-10 may be used alone, or both may be used in combination. May be used. Among these amphiphilic esters, bis (polyoxyalkylene alkyl ether) ester dicarboxylates are more preferable from the viewpoint of better skin irritation reduction and detergency.
本発明に使用されるジカルボン酸ビス(ポリオキシアルキレンアルキルエーテル)エステルは、ジカルボン酸とポリオキシアルキレンアルキルエーテルとのジエステル化合物である。ジカルボン酸ビス(ポリオキシアルキレンアルキルエーテル)エステルのジエステル化合物を構成するジカルボン酸の具体例としては、例えば、シュウ酸、マロン酸、コハク酸、酒石酸、リンゴ酸、グルタル酸、アジピン酸、ペメリン酸、スベリン酸、アゼライン酸、セバシン酸、アスパラギン酸、グルタミン酸、アセトンジカルボン酸、フタル酸、シクロヘキサン−1,4−ジカルボン酸などが挙げられる。また、ジエステル化合物を構
成するポリオキシアルキレンアルキルエーテルとしては、例えば、ポリオキシエチレンモノアルキルエーテルなどが挙げられ、より具体的には、例えば、ジエチレングリコールモノエチルエーテル、トリエチレングリコールモノエチルエーテルなどが挙げられる。
The dicarboxylic acid bis (polyoxyalkylene alkyl ether) ester used in the present invention is a diester compound of a dicarboxylic acid and a polyoxyalkylene alkyl ether. Specific examples of the dicarboxylic acid constituting the diester compound of the dicarboxylic acid bis (polyoxyalkylene alkyl ether) ester include, for example, oxalic acid, malonic acid, succinic acid, tartaric acid, malic acid, glutaric acid, adipic acid, pemelic acid, Examples include suberic acid, azelaic acid, sebacic acid, aspartic acid, glutamic acid, acetonedicarboxylic acid, phthalic acid, cyclohexane-1,4-dicarboxylic acid, and the like. Examples of the polyoxyalkylene alkyl ether constituting the diester compound include, for example, polyoxyethylene monoalkyl ether, and more specifically, for example, diethylene glycol monoethyl ether, triethylene glycol monoethyl ether, and the like. Can be
これらのジカルボン酸ビス(ポリオキシアルキレンアルキルエーテル)エステルの中でも、皮膚刺激低減性及び洗浄力をより良好に得る観点から、好ましくは、シクロヘキサン−1,4−ジカルボン酸とジエチレングリコールモノエチルエーテルとのジエステル化合物、具体的には、INCI名(International Cosmetic Ingredient Dictionary and Handbook,第13版,第1巻,CTFA,2010年,p.331):BIS−ETHOXYDIGLYCOL CYCLOHEXANE 1,4−DICARBOXYLATEで表記される、シクロへキサン−1,4−ジカルボン酸ビスエトキシジグリコールと称される化合物、及びコハク酸とジエチレングリコールモノエチルエーテルとのジエステル化合物、具体的には、INCI名(International Cosmetic Ingredient Dictionary and Handbook,第13版,第1巻,CTFA,2010年,p.331−332):BIS−ETHOXYDIGLYCOL SUCCINATEで表記される、コハク酸ビスエトキシジグリコールと称される化合物が挙げられ、より好ましくは、シクロへキサン−1,4−ジカルボン酸ビスエトキシジグリコールが挙げられる。 Among these dicarboxylic acid bis (polyoxyalkylene alkyl ether) esters, from the viewpoint of better skin irritation reduction and detergency, preferably a diester of cyclohexane-1,4-dicarboxylic acid and diethylene glycol monoethyl ether. Compounds, specifically, INCI names (International Cosmetic Ingredient Dictionary and Handbook, 13th Edition, Volume 1, CTFA, 2010, p. 331): BIS-ETHOXYDIGLYCOL CYCLOHEXANE, 4-DIALBOARD Hexane-1,4-dicarboxylic acid compound called bisethoxydiglycol, succinic acid and diethylene glycol monoethyl ether Diester compound, specifically, INCI (International Cosmetic Ingredient Dictionary and Handbook, 13th edition, Volume 1, CTFA, 2010, p. 331-332): BIS-ETHOXYDIGLYCOL SUCCINATE A compound referred to as bisethoxydiglycolic acid is more preferred, and bisethoxydiglycol cyclohexane-1,4-dicarboxylate is more preferred.
また、本発明において、前記シクロへキサン−1,4−ジカルボン酸ビスエトキシジグリコールの具体例としては、例えば、日本精化株式会社製の「Neosolue−Aqulio(商品名)」等が挙げられる。また、前記コハク酸ビスエトキシジグリコールの具体例としては、例えば、高級アルコール工業株式会社製の「ハイアクオスター DCS(商品名)」等が挙げられる。 In the present invention, specific examples of the bisethoxydiglycol cyclohexane-1,4-dicarboxylate include "Neosolue-Aqulio (trade name)" manufactured by Nippon Seika Co., Ltd. Specific examples of the bisethoxydiglycol succinate include, for example, "HIAQOSTER DCS (trade name)" manufactured by Higher Alcohol Industry Co., Ltd.
これらのジカルボン酸ビス(ポリオキシアルキレンアルキルエーテル)エステルは、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。 These dicarboxylic acid bis (polyoxyalkylene alkyl ether) esters may be used alone or in a combination of two or more.
本発明に使用される(エイコサン二酸/テトラデカン二酸)ポリグリセリル−10としては、特に限定されないが、例えば、日本精化株式会社製の「Neosolue−Aqua(商品名)」、「Neosolue−AquaS(商品名)」等が挙げられる。 Polyglyceryl-10 (eicosane diacid / tetradecane diacid) used in the present invention is not particularly limited. For example, "Neosolue-Aqua (trade name)" or "Neosolue-AquaS (trade name)" manufactured by Nippon Seika Co., Ltd. (Product name) ”and the like.
本発明の皮膚洗浄用液体組成物における(B)成分の含有量としては特に限定されないが、例えば0.1重量%以上が挙げられる。洗浄力をより良好に得る観点から、(B)成分の含有量としては好ましくは0.5重量%以上が挙げられる。(B)成分の含有量の範囲の上限は特に限定されないが、皮膚洗浄用液体組成物の安定性等の観点から、例えば5重量%以下、好ましくは3重量%以下、より好ましくは2重量%以下が挙げられる。 The content of the component (B) in the liquid composition for skin cleansing of the present invention is not particularly limited, but examples include 0.1% by weight or more. From the viewpoint of obtaining better detergency, the content of the component (B) is preferably 0.5% by weight or more. Although the upper limit of the range of the content of the component (B) is not particularly limited, for example, 5% by weight or less, preferably 3% by weight or less, and more preferably 2% by weight from the viewpoint of the stability of the liquid composition for skin cleansing. The following are mentioned.
本発明の皮膚洗浄用液体組成物において、(A)成分と(B)成分との比率は特に限定されず、上記の各含有量により定まるが、皮膚刺激低減性及び洗浄力をより良好に得る観点から、(A)成分1重量部に対して(B)成分が例えば0.1〜100重量部、好ましくは0.1〜10重量部、より好ましくは0.5〜5重量部が挙げられる。 In the liquid composition for skin cleansing of the present invention, the ratio of the component (A) to the component (B) is not particularly limited and is determined by the above contents, but the skin irritation reducing property and the detergency are more preferably obtained. From the viewpoint, the component (B) is, for example, 0.1 to 100 parts by weight, preferably 0.1 to 10 parts by weight, more preferably 0.5 to 5 parts by weight with respect to 1 part by weight of the component (A). .
他の成分
本発明の皮膚洗浄用液体組成物には、前記成分の他に、本発明の効果を損なわない範囲で、製剤化等に必要とされる他の基剤や添加剤が含まれていてもよい。このような添加剤については、薬学的に許容されることを限度として特に制限されないが、例えば、水、炭素数1〜5の低級アルコール(エタノール、イソプロパノール等)、及び多価アルコール(エチレングリコール、1,3−ブチレングリコール(1,3−BG)、プロピレングリコール、イソプレングリコール、ジエチレングリコール、ジプロピレングリコール、ポリ
プロピレングリコール、グリセリン等)等の水性基剤;防腐剤(メチルパラベン、プロピルパラベン、安息香酸、安息香酸ナトリウム、ソルビン酸等)、着香剤(シトラール、1,8−シオネール、シトロネラール、ファルネソール等)、着色剤(タール色素(褐色201号、青色201号、黄色4号、黄色403号等)、カカオ色素、クロロフィル、酸化アルミニウム等)、粘稠剤(ヒドロキシプロピルセルロース、ヒドロキシエチルセルロース、架橋型アクリル酸重合体、カルボキシビニルポリマー、ヒプロメロース、ポリビニルピロリドン、アルギン酸ナトリウム、エチルセルロース、カルボキシメチルセルロースナトリウム、キサンタンガム、カラギーナン等)、pH調整剤(リン酸、塩酸、クエン酸、クエン酸ナトリウム、コハク酸、酒石酸、水酸化ナトリウム、水酸化カリウム、トリエタノールアミン、トリイソプロパノールアミン等)、湿潤剤(dl−ピロリドンカルボン酸ナトリウム液、D−ソルビトール液、マクロゴール等)、安定化剤(ジブチルヒドロキシトルエン、ブチルヒドロキシアニソール、エデト酸ナトリウム、メタリン酸ナトリウム、L−アルギニン、L−アスパラギン酸、DL−アラニン、グリシン、エリソルビン酸ナトリウム、没食子酸プロピル、亜硫酸ナトリウム、二酸化硫黄、クロロゲン酸、カテキン、ローズマリー抽出物等)、酸化防止剤、紫外線吸収剤、キレート剤、粘着剤、緩衝剤、溶解補助剤、可溶化剤、保存剤等の添加剤が挙げられる。これらの基材や添加剤は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。これらの基材や添加剤の含有量は、製剤形態等に応じて適宜設定することができる。
Other Ingredients The liquid composition for cleansing skin of the present invention contains, in addition to the aforementioned components, other bases and additives required for formulation and the like within a range not to impair the effects of the present invention. You may. Such additives are not particularly limited as long as they are pharmaceutically acceptable. For example, water, lower alcohols having 1 to 5 carbon atoms (ethanol, isopropanol, etc.), and polyhydric alcohols (ethylene glycol, Aqueous bases such as 1,3-butylene glycol (1,3-BG), propylene glycol, isoprene glycol, diethylene glycol, dipropylene glycol, polypropylene glycol, glycerin and the like; preservatives (methylparaben, propylparaben, benzoic acid, benzoic acid) Sodium acid, sorbic acid, etc.), flavoring agents (citral, 1,8-ionel, citronellal, farnesol, etc.), coloring agents (tar dyes (brown 201, blue 201, yellow 4, yellow 403, etc.)), Cocoa pigment, chlorophyll, aluminum oxide Etc.), thickeners (hydroxypropylcellulose, hydroxyethylcellulose, crosslinked acrylic acid polymer, carboxyvinyl polymer, hypromellose, polyvinylpyrrolidone, sodium alginate, ethylcellulose, sodium carboxymethylcellulose, xanthan gum, carrageenan, etc.), pH adjuster (phosphorus) Acid, hydrochloric acid, citric acid, sodium citrate, succinic acid, tartaric acid, sodium hydroxide, potassium hydroxide, triethanolamine, triisopropanolamine, etc.), wetting agent (dl-pyrrolidone carboxylate sodium solution, D-sorbitol solution, Macrogol, etc.), stabilizers (dibutylhydroxytoluene, butylhydroxyanisole, sodium edetate, sodium metaphosphate, L-arginine, L-aspartic acid, L-alanine, glycine, sodium erythorbate, propyl gallate, sodium sulfite, sulfur dioxide, chlorogenic acid, catechin, rosemary extract, etc.), antioxidants, ultraviolet absorbers, chelating agents, adhesives, buffers, dissolving Additives such as auxiliaries, solubilizers, preservatives and the like can be mentioned. These base materials and additives may be used alone or in a combination of two or more. The content of these base materials and additives can be appropriately set according to the formulation form and the like.
本発明の皮膚洗浄用液体組成物には、前記成分の他に、本発明の効果を損なわない範囲で、必要に応じて他の薬理成分を含有していてもよい。このような薬理成分としては、例えば、ビタミン類(ビタミンA類、ビタミンB1類、ビタミンB2類、ビタミンB5類、ビタミンB6類、ビタミンB12類、ビタミンC類、ビタミンD類、ビタミンK類、ナイアシン類、葉酸、ビオチン、リコペン等)、抗ヒスタミン剤(ジフェンヒドラミン、塩酸ジフェンヒドラミン等)、局所麻酔剤(プロカイン、テトラカイン、ブピバカイン、メピバカイン、クロロプロカイン、プロパラカイン、メプリルカイン又はこれらの塩、オルソカイン、オキセサゼイン、オキシポリエントキシデカン、ロートエキス、ペルカミンパーゼ、テシットデシチン等)、抗炎症剤(インドメタシン、フェルビナク、ジクロフェナクナトリウム、ロキソプロフェンナトリウム等)、皮膚保護剤(コロジオン、ヒマシ油等)、血行促進成分(ノニル酸ワニリルアミド、ニコチン酸ベンジルエステル、カプサイシン、トウガラシエキス等)、清涼化剤(メントール、カンフル、ボルネオール、ハッカ水、ハッカ油等)、ムコ多糖類(コンドロイチン硫酸ナトリウム、グルコサミン等)等が挙げられる。これらの薬理成分は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。これらの薬理成分を含有させる場合、その含有量については、使用する薬理成分の種類、期待する効果等に応じて適宜設定すればよい。 The liquid composition for skin cleansing of the present invention may contain other pharmacological components, if necessary, in addition to the above components, as long as the effects of the present invention are not impaired. Examples of such pharmacological components include vitamins (vitamin A, vitamin B1, vitamin B2, vitamin B5, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin K, niacin , Folic acid, biotin, lycopene, etc.), antihistamines (diphenhydramine, diphenhydramine hydrochloride, etc.), local anesthetics (procaine, tetracaine, bupivacaine, mepivacaine, chloroprocaine, proparacaine, mepricaine or salts thereof, orthocaine, oxesazein, oxypolyoxygen Decane, funnel extract, percaminepase, tesit decithin, etc., anti-inflammatory agents (indomethacin, felbinac, diclofenac sodium, loxoprofen sodium, etc.), skin protective agents (collodion, castor oil) ), Blood circulation promoting components (nonylate varnishylamide, nicotinic acid benzyl ester, capsaicin, pepper extract, etc.), fresheners (menthol, camphor, borneol, peppermint water, peppermint oil, etc.), mucopolysaccharides (sodium chondroitin sulfate, glucosamine, etc.) ) And the like. These pharmacological components may be used alone or in a combination of two or more. When these pharmacological components are contained, the content thereof may be appropriately set according to the type of the pharmacological components used, the expected effects, and the like.
形態
本発明の皮膚洗浄用液体組成物の形態は、常温で液状又はジェル状である。また、本発明の皮膚洗浄用液体組成物の粘度としては、20℃において10000mPa・s以下、好ましくは5000mPa・s以下が挙げられる。なお、粘度は、BL粘度計(ロ−ターNo3、6rpm、20℃)によって測定される値である。
Form The form of the liquid composition for cleaning skin of the present invention is liquid or gel at room temperature. Further, the viscosity of the liquid composition for skin cleansing of the present invention at 20 ° C. is 10,000 mPa · s or less, preferably 5000 mPa · s or less. The viscosity is a value measured by a BL viscometer (Rotor No. 3, 6 rpm, 20 ° C.).
容器
本発明の皮膚洗浄用液体組成物を収容する容器については、容器内から皮膚洗浄用液体組成物を直接肌に適用することが可能なものであれば特に限定されず、例えば、噴霧式容器、注下又は滴下式容器(特に洗浄瓶)が挙げられ、エステサロンや美容院における施術容易性の観点からは、好ましくは注下又は滴下式容器(特に洗浄瓶)が挙げられる。なお
、本発明における噴霧式容器は、内容物をミスト状態で吐出するものであり、いずれも、皮膚洗浄用液体組成物を泡状態で吐出するポンプフォーマー容器とは異なる。
Container The container containing the liquid composition for cleaning skin of the present invention is not particularly limited as long as the liquid composition for cleaning skin can be directly applied to the skin from inside the container. And a dropping or dropping type container (especially a washing bottle). From the viewpoint of ease of treatment in a beauty salon or a beauty salon, preferably a pouring or dropping type container (especially a washing bottle). The spray-type container of the present invention discharges the contents in a mist state, and is different from a pump former container which discharges the skin-cleaning liquid composition in a foam state.
本発明においては、このように皮膚洗浄用液体組成物を噴霧式容器、注下又は滴下式容器(特に洗浄瓶)に収容することにより、肌への適用の前に泡立てることなく、皮膚洗浄用液体組成物が直接的に肌に塗布される。従って、肌への塗布が手軽であり且つ塗布時における手等による物理摩擦及び/又は洗浄時の泡による物理摩擦を回避することができる。噴霧式容器としては、非エアゾール式スプレー容器であるポンプ式スプレー容器、及び、エアゾール式スプレー容器が挙げられる。噴霧式容器の口径(ノズル内径)としては、例えば0.01〜3mmφ、好ましくは0.1〜1mmφが挙げられる。噴霧式容器がポンプ式スプレー容器である場合の1プッシュあたりの噴射量としては、例えば0.05〜1.2g、好ましくは0.1〜0.3gが挙げられる。 In the present invention, the skin cleansing liquid composition is contained in a spray-type container, a pouring or dropping type container (particularly, a cleaning bottle), and thus is not lathered before application to the skin. The liquid composition is applied directly to the skin. Therefore, application to the skin is easy, and physical friction due to hands or the like during application and / or physical friction due to foam during washing can be avoided. The spray type container includes a pump type spray container which is a non-aerosol type spray container, and an aerosol type spray container. The diameter (nozzle inner diameter) of the spray-type container is, for example, 0.01 to 3 mmφ, preferably 0.1 to 1 mmφ. When the spray container is a pump spray container, the injection amount per push is, for example, 0.05 to 1.2 g, preferably 0.1 to 0.3 g.
用途
本発明の皮膚洗浄用液体組成物は、皮膚の油脂、汗などの体液や汚れ等を除去するために用いられるものであり、化粧落とし(クレンジング)として用いられるものではない。本発明の皮膚洗浄用液体組成物は、エステサロンや美容院における洗顔施術用途に用いられる。本発明の皮膚洗浄用液体組成物は、水で薄めることなく、泡立てずにそのまま皮膚に塗布することで使用する。1回当たりの使用量としては、界面活性剤の濃度及び汚れの程度等にもよるが、例えば洗顔に用いる場合0.5〜3g、好ましくは1〜2gが挙げられる。
Uses The skin cleansing liquid composition of the present invention is used for removing body fluids such as fats and oils and sweat, dirt, and the like, and is not used for removing makeup (cleansing). The liquid composition for skin cleansing of the present invention is used for facial cleansing in beauty salons and beauty salons. The skin cleansing liquid composition of the present invention is used by applying it to the skin without diluting with water and without foaming. The amount used at one time depends on the concentration of the surfactant, the degree of dirt, and the like, but for example, 0.5 to 3 g, preferably 1 to 2 g when used for face washing.
より具体的には、皮膚洗浄用液体組成物を手に取ることなく、直接的に噴霧式容器、注下又は滴下式容器(特に洗浄瓶)から洗浄対象部位に塗布することができる。このように、皮膚洗浄用液体組成物を直接的に洗浄対象部位に塗布することで、洗浄対象部位の皮膚と手との間に生じる摩擦や、洗浄部位の皮膚と気泡と間に生じる摩擦といった物理的摩擦を一切与えることなく、液流の機械力を利用するだけで洗浄することが可能になる。本発明の皮膚洗浄用液体組成物は、洗浄力に優れた処方であるため、このように物理的摩擦を与えずに液流の機械力を利用して洗浄することで、洗浄時における肌への負担が顕著に軽減され極めて優しい洗浄方法が可能となる。このように泡立てない洗浄方法は、素早い洗浄を可能とし、界面活性剤が少なく肌に優しいことも実感しやすく、肌に優しい洗浄を追及する意識が高い消費者の満足感も得られやすくなる。 More specifically, the skin cleaning liquid composition can be directly applied to a site to be cleaned from a spray-type container, a pouring or dropping-type container (particularly, a cleaning bottle) without picking up the liquid composition. As described above, by directly applying the skin cleaning liquid composition to the site to be cleaned, friction between the skin of the site to be cleaned and the hand, friction between the skin of the site to be cleaned, and air bubbles, etc. Without applying any physical friction, cleaning can be performed only by utilizing the mechanical force of the liquid stream. Since the skin cleansing liquid composition of the present invention is a formulation having an excellent detergency, by using the mechanical force of the liquid flow without imparting physical friction in this way, it is applied to the skin during cleaning. Is remarkably reduced, and a very gentle cleaning method becomes possible. Such a non-foaming cleaning method enables quick cleaning, and makes it easy to realize that the amount of surfactant is low and that it is gentle on the skin, and that the consumer who is highly conscious of pursuing skin-friendly cleaning is easily satisfied.
本発明の皮膚洗浄用液体組成物の洗浄対象部位としては、あらゆる身体部位の洗浄が可能であるため特に制限されず、例えば、手、髪、頭皮、体、顔等が挙げられる。また、本発明の皮膚洗浄用液体組成物が物理的摩擦を皮膚に与えることなく優れた洗浄力を発揮することができるため、刺激に対して敏感な顔への使用において好適である。 The site to be washed with the liquid composition for cleaning skin of the present invention is not particularly limited because it can wash any body part, and includes, for example, hands, hair, scalp, body, face and the like. Further, the skin cleansing liquid composition of the present invention can exhibit excellent cleansing power without giving physical friction to the skin, and thus is suitable for use on a face that is sensitive to irritation.
洗浄後、皮膚洗浄用液体組成物は、水で洗い流すことができる。水で洗い流す場合も、手による物理的摩擦を与えないように水流の機械力を利用して洗い流す。洗い流しに用いる水も、噴霧式容器、注下又は滴下式容器(特に洗浄瓶)、好ましくは注下又は滴下式容器(特に洗浄瓶)に収容し、皮膚洗浄用液体組成物と同様に洗浄対象部位に適用することができる。 After washing, the skin cleansing liquid composition can be washed away with water. When washing away with water, the washing is performed using the mechanical force of the water stream so as not to give physical friction by hand. The water used for rinsing is also contained in a spray container, a pouring or dripping container (especially a washing bottle), preferably a pouring or dripping container (especially a washing bottle), and is to be cleaned in the same manner as the skin cleaning liquid composition. Can be applied to the site.
また、本発明の皮膚洗浄用液体組成物は、界面活性剤濃度を極端に低くすることができるため、この場合、洗浄後に洗い流さなくてもよい。このため、本発明の皮膚洗浄用液体組成物は、病院における清拭用途、エステサロンや美容院における洗顔等皮膚洗浄施術用途、及び災害用品用途等でも好適である。洗い流さない場合、タオルやティッシュ等の吸水性基材を用いてこすらないように洗浄部位に残存した皮膚洗浄用液体組成物を吸い取って除去してもよい。 In addition, the skin cleaning liquid composition of the present invention can extremely reduce the surfactant concentration, and in this case, does not have to be washed off after washing. For this reason, the liquid composition for skin cleansing of the present invention is also suitable for wiping use in hospitals, skin cleansing applications such as face washing in beauty salons and beauty salons, and disaster product use. In the case of not rinsing, the liquid composition for skin cleaning remaining at the cleaning site may be removed by suction so as not to rub with a water-absorbing substrate such as a towel or tissue.
製造方法
本発明の皮膚洗浄用液体組成物は、前述する(A)成分及び(B)成分、並びに必要に応じて配合される他の成分等を混合して、所定の形態に調製することによって製造される。
Manufacturing Method The liquid composition for skin cleansing of the present invention is prepared by mixing the above-mentioned components (A) and (B), and other components to be blended as required, and preparing the mixture into a predetermined form. Manufactured.
2.皮膚洗浄方法
前述するように、両親媒性エステルは、界面活性剤を含む皮膚洗浄料組成物において、物理的摩擦を皮膚に与えることなく、洗浄力を向上させることができる。従って、本発明は、更に、(A)成分である界面活性剤と共に、(B)成分である両親媒性エステルを含有する皮膚洗浄用液体組成物を、物理的摩擦を皮膚に与えることなく皮膚に適用することを含む皮膚洗浄方法を提供する。本発明の皮膚洗浄方法は、エステサロンや美容院で行われる洗浄施術として実施することができる。
2. Skin Cleansing Method As described above, amphiphilic esters can improve the cleansing power of a skin cleansing composition containing a surfactant without imparting physical friction to the skin. Therefore, the present invention further provides a skin cleansing liquid composition containing the (B) component amphiphilic ester together with the (A) component surfactant, without giving physical friction to the skin. A skin cleaning method comprising applying to the skin. The skin cleaning method of the present invention can be carried out as a cleaning treatment performed in a beauty salon or a beauty salon.
前記皮膚洗浄方法において、使用する成分の種類や使用量、皮膚洗浄料組成物の形態等については、前記「1.皮膚洗浄用液体組成物」の欄に示す通りである。 In the skin cleansing method, the types and amounts of the components used, the form of the skin cleanser composition, and the like are as shown in the above-mentioned “1. Liquid composition for skin cleansing”.
以下に実施例を示して本発明をより具体的に説明するが、本発明はこれらに限定されるものではない。 Hereinafter, the present invention will be described more specifically with reference to Examples, but the present invention is not limited thereto.
表1〜4に示す組成の皮膚洗浄用液体組成物を調製した。表1〜4に示す各成分の詳細は以下の通りである。なお、表1〜4に示す皮膚洗浄用液体組成物は液状であり、20℃における粘度(BL粘度計(ブルックフィールド社製B型粘度計)ロ−ターNo3、6rpmによって測定)は、いずれも5000mPa・s以下の範囲にあった。
・ラウリン酸ナトリウム(日油株式会社製「ノンサールLN−1」(商品名)
・ココイルグルタミン酸TEA(味の素株式会社製「アミソフトCT−12S(商品名)」)
・ココイルメチルタウリンNa(日油株式会社製「ダイヤポンK−SF(商品名)」)
・N−ラウロイルアスパラギン酸ナトリウム液(20重量%)(旭化成ファインケミカル株式会社製「アミノフォーマー FLDS−L(商品名)」)
・ポリオキシエチレンラウリルエーテル酢酸(花王株式会社製「カオーアキポRLM−45(商品名)」)
・コカミドDEA(川研ファインケミカル株式会社製「アミゾールCDE−G(商品名)」)
・PEG-60水添ヒマシ油(ポリオキシエチレン硬化ヒマシ油;日光ケミカルズ株式会社製 「NIKKOL HCO−60(商品名)」)
・モノステアリン酸ポリオキシエチレンソルビタン(花王株式会社製 レオドールTW−S120V)
・グリセリンモノ−2−エチルヘキシルエーテル(SEPPIC社製「sensiva
SC 50 JP(商品名)」)
・コカミドプロピルベタイン(川研ファインケミカル株式会社製「ソフタゾリンCPB(商品名)」)
・ラウリルヒドロキシスルホベタイン液(30重量%)(花王株式会社製「アンヒトール20HD(商品名)」)
・リゾレシチン(協和発酵バイオ株式会社製「リゾレシチン協和(商品名)」)
・キラヤエキス(丸善製薬株式会社製「キラヤ抽出液BG」、サポニン含量5重量%)
・シクロヘキサン−1,4−ジカルボン酸ビスエトキシジグリコール(日本精化株式会社製「Neosolue−Aqulio(商品名)」)
・コハク酸ビスエトキシジグリコール(高級アルコール工業株式会社製「ハイアクオスター DCS(商品名)」)
Skin cleaning liquid compositions having the compositions shown in Tables 1 to 4 were prepared. Details of each component shown in Tables 1 to 4 are as follows. The skin cleansing liquid compositions shown in Tables 1 to 4 are liquid, and all of the viscosities at 20 ° C (measured with a BL viscometer (Brookfield B-type viscometer) rotor No. 3 and 6 rpm). It was in the range of 5000 mPa · s or less.
・ Sodium laurate (“NON-SAL LN-1” (trade name) manufactured by NOF CORPORATION)
・ Cocoyl glutamate TEA (“Amisoft CT-12S (brand name)” manufactured by Ajinomoto Co., Inc.)
・ Cocoyl methyl taurine Na (“Diapon K-SF (trade name)” manufactured by NOF Corporation)
・ Sodium N-lauroyl aspartate solution (20% by weight) (“Aminoformer FLDS-L (brand name)” manufactured by Asahi Kasei Fine Chemical Co., Ltd.)
・ Polyoxyethylene lauryl ether acetic acid (Kaohakipo RLM-45 (trade name) manufactured by Kao Corporation)
-Cocamide DEA ("Amizole CDE-G (trade name)" manufactured by Kawaken Fine Chemical Co., Ltd.)
-PEG-60 hydrogenated castor oil (polyoxyethylene hydrogenated castor oil; NIKKOL HCO-60 (trade name) manufactured by Nikko Chemicals Co., Ltd.)
・ Polyoxyethylene sorbitan monostearate (Reodol TW-S120V manufactured by Kao Corporation)
-Glycerin mono-2-ethylhexyl ether ("Sensiva" manufactured by SEPPIC)
SC 50 JP (brand name) ")
・ Cocamidopropyl betaine (“Softazoline CPB (trade name)” manufactured by Kawaken Fine Chemical Co., Ltd.)
・ Lauryl hydroxysulfobetaine solution (30% by weight) (“Amphitol 20HD (trade name)” manufactured by Kao Corporation)
・ Lyso-lecithin (“Lyso-lecithin Kyowa (brand name)” manufactured by Kyowa Hakko Bio Co., Ltd.)
・ Kiraya extract (“Kiraya extract BG” manufactured by Maruzen Pharmaceutical Co., Ltd., saponin content 5% by weight)
-Bisethoxydiglycol cyclohexane-1,4-dicarboxylate ("Neosolue-Aqulio (trade name)" manufactured by Nippon Seika Co., Ltd.)
・ Bisethoxydiglycol succinate (“HIAQOSTER DCS (trade name)” manufactured by Higher Alcohol Industry Co., Ltd.)
<洗浄力評価>
調製した皮膚洗浄用液体組成物について、化粧品評価専門パネラー10名が洗浄力評価を行った。具体的には、各皮膚洗浄用液体組成物をポンプ式スプレー容器(竹本容器株式会社製「Z−155−C110(商品名)」1プッシュあたりの噴射量は0.15g)に収容し、1.5gを顔に直接的に噴霧することで塗布した。5秒程度放置し、その後、手が顔に触れないように水で洗い流した。タオルで顔を抑えて水を吸い取った後、肌の汚れ落ち感を以下の指標に基づいて官能評価することで採点した。
<Evaluation of detergency>
About the prepared skin cleaning liquid composition, 10 panelists specializing in cosmetics evaluation evaluated the detergency. Specifically, each of the liquid compositions for cleaning skin is contained in a pump type spray container (“Z-155-C110 (trade name)” manufactured by Takemoto Container Co., Ltd., the injection amount per push is 0.15 g), and 0.5 g was applied by spraying directly on the face. It was left for about 5 seconds, and then washed with water so that the hands did not touch the face. After the face was suppressed with a towel and water was absorbed, the feeling of dirt on the skin was evaluated by sensory evaluation based on the following indices.
5点:汚れ落ちがしっかり感じられた
4点:汚れ落ちが感じられた
3点:どちらでもない
2点:汚れ落ちがあまり感じられない
1点:汚れ落ちが全く感じられない
5 points: Dirt was felt firmly 4 points: Dirt was felt 3 points: Neither 2 points: Dirt was not felt much 1 point: Dirt was not felt at all
パネラー10名の獲得スコアを合計し、以下の分類により洗浄力の程度を評価した。結果を表1〜4に示す。
◎:45点以上
○:40点以上45点未満
△:35点以上40点未満
×:35点未満
The obtained scores of 10 panelists were totaled, and the degree of detergency was evaluated according to the following classification. The results are shown in Tables 1 to 4.
◎: 45 points or more
:: 40 or more and less than 45
△: 35 points or more and less than 40 points
×: less than 35 points
<つっぱり感評価(肌刺激性の官能評価)>
調製した皮膚洗浄用液体組成物について、化粧品評価専門パネラー10名がつっぱり感評価を行った。具体的には、各皮膚洗浄用液体組成物をポンプ式スプレー容器(竹本容器株式会社製「Z−155−C110(商品名)」(1プッシュあたりの噴射量は0.15g)に収容し、1.5gを顔に直接的に噴霧することで塗布した。5秒程度放置し、その後、手が顔に触れないように水で洗い流した。タオルで顔を抑えて水を吸い取った後、つっぱり感を以下の指標に基づいて官能評価することで採点した。
<Tightness evaluation (Sensory evaluation of skin irritation)>
The prepared skin cleansing liquid composition was evaluated by ten panelists specializing in cosmetics evaluation. Specifically, each skin cleansing liquid composition is contained in a pump type spray container ("Z-155-C110 (trade name)" manufactured by Takemoto Container Co., Ltd. (the injection amount per push is 0.15 g), 1.5 g was applied by spraying directly on the face, left for about 5 seconds, and then rinsed with water so that hands would not touch the face. The feeling was scored by sensory evaluation based on the following indices.
5点:つっぱり感を全く感じない
4点:つっぱり感をほとんど感じない
3点:つっぱり感をわずかしか感じない
2点:つっぱり感を感じる
1点:つっぱり感を強く感じる
5 points: No feeling of tightness at all 4 points: Little feeling of feeling of tightness 3 points: Feel only a little feeling of tightness 2 points: Feeling of feeling of tightness 1 point: Strong feeling of feeling of tightness
パネラー10名の獲得スコアを合計し、以下の分類によりつっぱり感の程度を評価した。結果を表3〜4に示す。
◎:45点以上
○:40点以上45点未満
△:35点以上40点未満
×:35点未満
The acquired scores of the ten panelists were totaled, and the degree of tightness was evaluated by the following classification. The results are shown in Tables 3 and 4.
◎: 45 points or more
:: 40 or more and less than 45
△: 35 points or more and less than 40 points
×: less than 35 points
<培養表皮皮膚刺激試験(肌刺激性のin vitro評価)>
調製した皮膚洗浄用液体組成物について、以下の通りに培養表皮皮膚刺激試験を行った。
1.培養表皮モデルLabCyte EPI−MODEL24の準備
アッセイ培地を温め、24ウェルアッセイプレートに0.5mLずつ添加した。培養表皮モデルLabCyte EPI−MODEL24(ロット番号:LCE24−180226−A)を、アッセイ培地を添加した24ウェルアッセイプレートに移した。培養カップ底面に気泡が無いことを確認し、CO2インキュベーターに入れ被験物質暴露まで1時
間以上静置した。
<Culture epidermis skin irritation test (in vitro evaluation of skin irritation)>
The prepared skin cleansing liquid composition was subjected to a cultured epidermal skin irritation test as follows.
1. Preparation of Culture Epidermal Model LabCyte EPI-MODEL24 The assay medium was warmed and added in 0.5 mL portions to a 24-well assay plate. The cultured epidermis model LabCyte EPI-MODEL24 (Lot No .: LCE24-180226-A) was transferred to a 24-well assay plate to which assay medium was added. After confirming that there were no bubbles on the bottom of the culture cup, the culture cup was placed in a CO 2 incubator and allowed to stand for 1 hour or more until exposure to the test substance.
2.被験物質の適用及び洗浄
表皮モデル24個のうち、12個を使用した(残りは本試験まで前培養を続けた)。24ウェルアッセイプレートをCO2インキュベーターから取り出した。アッセイ培地を温
め、24ウェルアッセイプレート第3行に1.0mLずつ添加した。被験物質(各皮膚洗浄用液体組成物)をポンプ式スプレー容器を用いずに培養カップの培養表皮に25μL滴下し、全体にいきわたらせて暴露した。暴露後1分、5分、10分経過時に被験物質を吸引除去し、カップ内の培養表皮モデルをリン酸緩衝液(PBS)で洗浄し、24ウェルアッセイプレート第3行に移した。
2. Application and washing of test substance Out of 24 epidermal models, 12 were used (the rest continued preculture until this test). The 24-well assay plates were removed from the CO 2 incubator. The assay medium was warmed and added to the third row of the 24-well assay plate in 1.0 mL portions. A test substance (each skin cleaning liquid composition) was dropped to the culture epidermis of the culture cup without using a pump-type spray container, and 25 μL of the substance was exposed to the whole. At 1, 5 and 10 minutes after the exposure, the test substance was aspirated off, and the cultured epidermis model in the cup was washed with phosphate buffer (PBS) and transferred to the third row of a 24-well assay plate.
3.MTT試験
MTT試験は、細胞内に取り込まれたMTT[3−(4,5−dimethylthiazol−2−yl)−2,5−diphenyltetrazolium bromide]が細胞内にあるミトコンドリアの脱水素酵素によって還元されて生じるフォルマザン色素を、有機溶媒により抽出して570nmの吸光度を測定することで生細胞率を計測する方法である。
3. MTT test The MTT test is produced by reducing MTT [3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide] taken up into cells by mitochondrial dehydrogenase in the cells. This is a method of measuring the viable cell rate by extracting a formazan dye with an organic solvent and measuring the absorbance at 570 nm.
MTT培地を終濃度0.5mg/mLで10mL調製した。MTT培地を温め、24ウェルアッセイプレート第4行に0.5mLずつ添加した。培養表皮モデルを24ウェルアッセイプレート第4行に移し、CO2インキュベーターに入れて、3時間MTT反応を行った。MTT反応終了後、培養皮膚をピンセットでつまんで取り出し、1.5mLマイクロチューブに移した。マイクロチューブにイソプロパノール300μLを入れて培養表皮モデルを完全に浸漬した。その後2時間静置し、マイクロチューブをボルテックスにかけ、色素を抽出した。抽出液(200mL)を96ウェルプレートの各ウェルに入れた。また、ブランク(陰性対照)として、A1にイソプロパノール200μLを入れた。マイクロプレートリーダーで570nm、650nmの吸光度を測定した。570nmの吸光度から650nmの吸光度を差し引いた値を測定値とし、下記式より被験物質の生細胞率を計算した。 10 mL of MTT medium was prepared at a final concentration of 0.5 mg / mL. The MTT medium was warmed and added to the fourth row of the 24-well assay plate in 0.5 mL portions. The cultured epidermis model was transferred to the fourth row of a 24-well assay plate, placed in a CO2 incubator, and subjected to an MTT reaction for 3 hours. After the completion of the MTT reaction, the cultured skin was pinched with tweezers, taken out, and transferred to a 1.5 mL microtube. 300 μL of isopropanol was placed in a microtube, and the cultured epidermis model was completely immersed. Thereafter, the mixture was allowed to stand for 2 hours, and the microtube was vortexed to extract a dye. Extract (200 mL) was placed in each well of a 96-well plate. As a blank (negative control), 200 μL of isopropanol was added to A1. The absorbance at 570 nm and 650 nm was measured with a microplate reader. The value obtained by subtracting the absorbance at 650 nm from the absorbance at 570 nm was used as the measured value, and the viable cell rate of the test substance was calculated from the following formula.
生細胞率を以下の基準に基づいて分類し、肌刺激性を評価した。結果を表3〜4に示す。
◎:90%以上
○:75%以上90%未満
△:65%以上75%未満
×:50%以上65%未満
××:50%未満
The viable cell rate was classified based on the following criteria, and the skin irritation was evaluated. The results are shown in Tables 3 and 4.
◎: 90% or more
:: 75% or more and less than 90%
Δ: 65% or more and less than 75%
×: 50% or more and less than 65% XX: less than 50%
表1〜4に示すとおり、界面活性剤を単独で0.025〜2重量%の濃度で含む皮膚洗浄用液体組成物(比較例1〜10)では洗浄力が認められなかった。これに対し、単独では洗浄力を示さない両親媒性エステル(比較例11〜15)を0.025〜2重量%の界面活性剤とともに含む皮膚洗浄用液体組成物(実施例1〜20)では、噴霧式容器から噴霧により直接肌に塗布するだけで、物理的摩擦を一切与えることなく、液流の機械力を利用するだけで優れた洗浄力が得られた。つまり、肌に優しい洗浄が可能であることが示された。 As shown in Tables 1 to 4, no detergency was observed in the skin cleansing liquid compositions containing the surfactant alone at a concentration of 0.025 to 2% by weight (Comparative Examples 1 to 10). On the other hand, the skin cleansing liquid composition (Examples 1 to 20) containing the amphiphilic ester (Comparative Examples 11 to 15) which does not show detergency by itself together with 0.025 to 2% by weight of a surfactant. Excellent detergency was obtained by merely applying the mechanical force of the liquid flow without applying any physical friction by simply applying directly to the skin by spraying from a spray-type container. That is, it was shown that skin-friendly cleaning was possible.
なお、参考例1〜3に示すように界面活性剤を単独で2重量%超含む皮膚洗浄用液体組成物も、噴霧により直接肌に塗布するだけで優れた洗浄力が得られる。一方で、参考例1〜3に示される界面活性剤濃度による皮膚刺激を考慮し、実施例9〜20に示されるように界面活性剤濃度を2重量%以下にすると、洗浄力だけでなく優れた低刺激性も奏された。つまり、噴霧により直接肌に塗布する洗浄方法に適用される皮膚洗浄用液体組成物の界面活性剤濃度を0.025〜2重量%とすることで、物理的にも化学的にも肌に優しい洗浄が可能となることが示された。 In addition, as shown in Reference Examples 1 to 3, a skin cleansing liquid composition containing a surfactant alone in an amount of more than 2% by weight can obtain excellent cleansing power only by directly applying it to the skin by spraying. On the other hand, in consideration of skin irritation due to the surfactant concentration shown in Reference Examples 1 to 3, when the surfactant concentration is set to 2% by weight or less as shown in Examples 9 to 20, not only the detergency but also the superiority is obtained. It was also hypoallergenic. That is, by setting the surfactant concentration of the liquid for skin cleaning applied to the cleaning method of directly applying to the skin by spraying to 0.025 to 2% by weight, the skin is physically and chemically friendly. It has been shown that washing is possible.
Claims (6)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018122525 | 2018-06-27 | ||
JP2018122525 | 2018-06-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020007305A true JP2020007305A (en) | 2020-01-16 |
JP7360826B2 JP7360826B2 (en) | 2023-10-13 |
Family
ID=69150762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019119217A Active JP7360826B2 (en) | 2018-06-27 | 2019-06-27 | Liquid composition for skin cleansing |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7360826B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020262158A1 (en) * | 2019-06-26 | 2020-12-30 | 小林製薬株式会社 | Liquid composition for cleaning skin |
WO2020262157A1 (en) * | 2019-06-26 | 2020-12-30 | 小林製薬株式会社 | Skin-cleansing spray |
WO2021124497A1 (en) * | 2019-12-18 | 2021-06-24 | 小林製薬株式会社 | Liquid composition for skin cleansing |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11310514A (en) * | 1998-02-24 | 1999-11-09 | Kao Corp | Selective removal of sebum |
JP2000273485A (en) * | 1999-03-23 | 2000-10-03 | Nisshin Kagaku Kk | Aerosol composition |
JP2015199684A (en) * | 2014-04-08 | 2015-11-12 | ホーユー株式会社 | Detergent composition and method for inhibiting skin irritation using the same |
-
2019
- 2019-06-27 JP JP2019119217A patent/JP7360826B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11310514A (en) * | 1998-02-24 | 1999-11-09 | Kao Corp | Selective removal of sebum |
JP2000273485A (en) * | 1999-03-23 | 2000-10-03 | Nisshin Kagaku Kk | Aerosol composition |
JP2015199684A (en) * | 2014-04-08 | 2015-11-12 | ホーユー株式会社 | Detergent composition and method for inhibiting skin irritation using the same |
Non-Patent Citations (1)
Title |
---|
"クレンジングに付加価値を与える機能性エステル", FRAGRANCE JOURNAL, vol. 433, JPN6023013423, 15 July 2016 (2016-07-15), JP, pages 51 - 55, ISSN: 0005026814 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020262158A1 (en) * | 2019-06-26 | 2020-12-30 | 小林製薬株式会社 | Liquid composition for cleaning skin |
WO2020262157A1 (en) * | 2019-06-26 | 2020-12-30 | 小林製薬株式会社 | Skin-cleansing spray |
WO2021124497A1 (en) * | 2019-12-18 | 2021-06-24 | 小林製薬株式会社 | Liquid composition for skin cleansing |
Also Published As
Publication number | Publication date |
---|---|
JP7360826B2 (en) | 2023-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7471780B2 (en) | Skin cleansing spray | |
JP6469949B2 (en) | Skin cleansing composition for body odor control | |
JP7360826B2 (en) | Liquid composition for skin cleansing | |
TW202114619A (en) | Skin-cleansing spray | |
JP2023184664A (en) | Skin cleanser composition | |
WO2020262154A1 (en) | Skin cleanser composition | |
JP2024019604A (en) | Skin cleansing composition | |
JP2020002049A (en) | External composition | |
WO2020262152A1 (en) | Spray agent for cleaning skin | |
WO2020262151A1 (en) | Skin cleanser composition | |
JP7344020B2 (en) | Liquid composition for skin cleansing | |
JP2020002050A (en) | Skin washing agent composition | |
WO2020262155A1 (en) | Spray agent for skin cleansing | |
WO2020262156A1 (en) | Liquid composition for skin cleansing | |
WO2020262153A1 (en) | Liquid composition for skin cleansing | |
WO2021124496A1 (en) | Spray preparation for skin cleaning | |
WO2021124497A1 (en) | Liquid composition for skin cleansing | |
WO2021124495A1 (en) | Skin cleanser composition | |
JP7554042B2 (en) | Skin cleansing composition | |
JP7364502B2 (en) | skin cleansing composition | |
JP2022100948A (en) | Aid for removal of keratotic plugs | |
JP2022061049A (en) | Skin cleansing composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220526 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230404 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230605 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230905 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20231002 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7360826 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |